$HDSN
HUDSON TECHNOLOGIES INC /NY

2023 Q4 Form 10-Q Financial Statement

#000141057823002221 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $44.86M $76.50M $89.50M
YoY Change -5.45% -14.53% 47.58%
Cost Of Revenue $30.89M $45.92M $45.26M
YoY Change -3.8% 1.44% 22.44%
Gross Profit $13.97M $30.58M $44.24M
YoY Change -8.91% -30.88% 86.84%
Gross Profit Margin 31.14% 39.98% 49.43%
Selling, General & Admin $8.532M $6.760M $7.219M
YoY Change 13.25% -6.36% 18.89%
% of Gross Profit 61.07% 22.11% 16.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.474M $1.410M $698.0K
YoY Change 111.17% 102.01% -54.79%
% of Gross Profit 10.55% 4.61% 1.58%
Operating Expenses $9.230M $7.458M $7.917M
YoY Change 12.12% -5.8% 16.94%
Operating Profit $4.740M $23.12M $36.32M
YoY Change -33.29% -36.34% 114.82%
Interest Expense -$246.0K $4.358M -$2.365M
YoY Change -87.91% -284.27% -16.81%
% of Operating Profit -5.19% 18.85% -6.51%
Other Income/Expense, Net -$246.0K -$4.358M $0.00
YoY Change
Pretax Income $4.494M $18.76M $33.96M
YoY Change -11.38% -44.74% 105.3%
Income Tax $549.0K $5.182M $4.601M
% Of Pretax Income 12.22% 27.62% 13.55%
Net Earnings $3.945M $13.58M $29.36M
YoY Change -22.34% -53.73% 84.98%
Net Earnings / Revenue 8.79% 17.76% 32.8%
Basic Earnings Per Share $0.30 $0.65
Diluted Earnings Per Share $0.08 $0.29 $622.2K
COMMON SHARES
Basic Shares Outstanding 45.50M 45.40M 45.02M
Diluted Shares Outstanding 47.35M 47.18M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.45M $3.800M $15.05M
YoY Change 135.05% -74.75% 58.36%
Cash & Equivalents $12.45M $3.783M $15.05M
Short-Term Investments
Other Short-Term Assets $7.492M $10.10M $18.74M
YoY Change 41.65% -46.11% 70.44%
Inventory $154.5M $139.2M $120.2M
Prepaid Expenses
Receivables $25.17M $44.94M $38.67M
Other Receivables $5.438M $0.00 $0.00
Total Short-Term Assets $205.0M $198.1M $192.6M
YoY Change 15.93% 2.84% 89.92%
LONG-TERM ASSETS
Property, Plant & Equipment $19.38M $20.57M $27.11M
YoY Change -5.8% -24.12% 35.3%
Goodwill $47.80M $47.80M
YoY Change 0.0%
Intangibles $14.77M $15.47M
YoY Change -15.9%
Long-Term Investments
YoY Change
Other Assets $3.137M $2.418M $762.0K
YoY Change 31.48% 217.32% 350.89%
Total Long-Term Assets $91.68M $93.30M $93.93M
YoY Change -4.16% -0.67% -1.86%
TOTAL ASSETS
Total Short-Term Assets $205.0M $198.1M $192.6M
Total Long-Term Assets $91.68M $93.30M $93.93M
Total Assets $296.7M $291.4M $286.6M
YoY Change 8.87% 1.69% 45.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.40M $16.80M $14.89M
YoY Change 65.19% 12.83% 122.37%
Accrued Expenses $12.26M $35.30M $39.93M
YoY Change 4.79% -11.6% 107.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $5.000M $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $5.000M $4.250M
YoY Change -100.0% 17.65% -19.02%
Total Short-Term Liabilities $58.55M $57.12M $59.07M
YoY Change 11.26% -3.31% 16.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $49.83M
YoY Change -100.0% -100.0% -32.89%
Other Long-Term Liabilities $4.790M $5.200M $6.178M
YoY Change -16.88% -15.83% 69.96%
Total Long-Term Liabilities $4.790M $5.200M $56.01M
YoY Change -87.71% -90.72% -24.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.55M $57.12M $59.07M
Total Long-Term Liabilities $4.790M $5.200M $56.01M
Total Liabilities $67.90M $66.81M $116.0M
YoY Change -30.44% -42.39% -10.93%
SHAREHOLDERS EQUITY
Retained Earnings $110.2M $106.3M
YoY Change 90.11%
Common Stock $455.0K $455.0K
YoY Change 0.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $228.8M $224.6M $170.6M
YoY Change
Total Liabilities & Shareholders Equity $296.7M $291.4M $286.6M
YoY Change 8.87% 1.69% 45.36%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $3.945M $13.58M $29.36M
YoY Change -22.34% -53.73% 84.98%
Depreciation, Depletion And Amortization $1.474M $1.410M $698.0K
YoY Change 111.17% 102.01% -54.79%
Cash From Operating Activities $15.03M $22.27M $26.15M
YoY Change 436.94% -14.83% 58.92%
INVESTING ACTIVITIES
Capital Expenditures $1.365M $1.380M -$895.0K
YoY Change -29.78% -254.19% 262.35%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.365M -$1.380M -$895.0K
YoY Change -29.78% 54.19% 262.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.001M -28.53M -30.89M
YoY Change -52.86% -7.63% 260.11%
NET CHANGE
Cash From Operating Activities 15.03M 22.27M 26.15M
Cash From Investing Activities -1.365M -1.380M -895.0K
Cash From Financing Activities -5.001M -28.53M -30.89M
Net Change In Cash 8.663M -7.640M -5.633M
YoY Change -188.81% 35.63% -173.83%
FREE CASH FLOW
Cash From Operating Activities $15.03M $22.27M $26.15M
Capital Expenditures $1.365M $1.380M -$895.0K
Free Cash Flow $13.66M $20.89M $27.04M
YoY Change 1498.13% -22.76% 61.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
dei Entity Central Index Key
EntityCentralIndexKey
0000925528
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45484325
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45287619
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13412
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
dei City Area Code
CityAreaCode
845
dei Local Phone Number
LocalPhoneNumber
735-6000
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
HDSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45502380
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3783000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5295000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44935000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20872000
CY2023Q3 us-gaap Inventory Net
InventoryNet
139231000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10143000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5289000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
198092000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
176833000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20570000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
CY2023Q3 us-gaap Goodwill
Goodwill
47803000
CY2022Q4 us-gaap Goodwill
Goodwill
47803000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15469000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17564000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7041000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7339000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2418000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2386000
CY2023Q3 us-gaap Assets
Assets
291393000
CY2022Q4 us-gaap Assets
Assets
272493000
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
16828000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
14165000
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30260000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
27908000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5030000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6303000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
5000000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
57118000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52626000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4524000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
244000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5167000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5763000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2023Q3 us-gaap Liabilities
Liabilities
66809000
CY2022Q4 us-gaap Liabilities
Liabilities
97618000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45484325
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45287619
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
455000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
453000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
117847000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116442000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
106282000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57980000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
224584000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
291393000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272493000
CY2023Q3 us-gaap Revenues
Revenues
76496000
CY2022Q3 us-gaap Revenues
Revenues
89502000
us-gaap Revenues
Revenues
244169000
us-gaap Revenues
Revenues
277781000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
45916000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
45263000
us-gaap Cost Of Revenue
CostOfRevenue
146632000
us-gaap Cost Of Revenue
CostOfRevenue
130225000
CY2023Q3 us-gaap Gross Profit
GrossProfit
30580000
CY2022Q3 us-gaap Gross Profit
GrossProfit
44239000
us-gaap Gross Profit
GrossProfit
97537000
us-gaap Gross Profit
GrossProfit
147556000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6760000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7219000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22010000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21057000
CY2023Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2095000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2095000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7458000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7917000
us-gaap Operating Expenses
OperatingExpenses
24105000
us-gaap Operating Expenses
OperatingExpenses
23152000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23122000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36322000
us-gaap Operating Income Loss
OperatingIncomeLoss
73432000
us-gaap Operating Income Loss
OperatingIncomeLoss
124404000
CY2023Q3 us-gaap Interest Expense
InterestExpense
4358000
CY2022Q3 us-gaap Interest Expense
InterestExpense
2365000
us-gaap Interest Expense
InterestExpense
8106000
us-gaap Interest Expense
InterestExpense
12293000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18764000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33957000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65326000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
112111000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5182000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4601000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17024000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13390000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
13582000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29356000
us-gaap Net Income Loss
NetIncomeLoss
48302000
us-gaap Net Income Loss
NetIncomeLoss
98721000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.10
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45404963
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45063810
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45348072
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44935739
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47345380
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47181424
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47319464
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47053010
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
140937000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
59000
CY2022Q3 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
10000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
247000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
29356000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
170589000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
211450000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2023Q3 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
690000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
240000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
13582000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
224584000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
182000
hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
83000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
830000
us-gaap Profit Loss
ProfitLoss
98721000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
170589000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000
hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
693000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2061000
us-gaap Profit Loss
ProfitLoss
48302000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
224584000
us-gaap Net Income Loss
NetIncomeLoss
48302000
us-gaap Net Income Loss
NetIncomeLoss
98721000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2213000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2455000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2095000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2095000
us-gaap Inventory Write Down
InventoryWriteDown
-2195000
us-gaap Inventory Write Down
InventoryWriteDown
-1155000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
800000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1711000
us-gaap Share Based Compensation
ShareBasedCompensation
2061000
us-gaap Share Based Compensation
ShareBasedCompensation
830000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
669000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2152000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3427000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4665000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4280000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-814000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24863000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26156000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8341000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24860000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
684000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9990000
hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
1000
hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
16000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4212000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3283000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10346000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43518000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60016000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2215000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1715000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2215000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1715000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
39000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
182000
hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-693000
hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-83000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
8512000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
5000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
47161000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
138331000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42815000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-46744000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1512000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11557000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3783000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15049000
us-gaap Interest Paid Net
InterestPaidNet
4232000
us-gaap Interest Paid Net
InterestPaidNet
10100000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16955000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9791000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
hdsn Allocation Allowance Received
AllocationAllowanceReceived
3000000
hdsn Allocation Allowance Received
AllocationAllowanceReceived
3000000
hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the nine month period ended September 30, 2023 there was one customer accounting for greater than 10% of the Company’s revenues and at September 30, 2023 there were $19.7 million of accounts receivable from this customer. For the nine-month period ended September 30, 2022 there was no customer accounting for 10% of the Company’s revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 hdsn Cylinder Deposit Value
CylinderDepositValue
16600000
CY2022Q4 hdsn Cylinder Deposit Value
CylinderDepositValue
13600000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11600000
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3500000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3500000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
13582000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
29356000
us-gaap Net Income Loss
NetIncomeLoss
48302000
us-gaap Net Income Loss
NetIncomeLoss
98721000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45404963
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45063810
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45348072
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44935739
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1940417
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2117614
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1971392
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2117271
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47345380
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47181424
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47319464
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47053010
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7444
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2743
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7444
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2980
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties, and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrofluorocarbon (“HFC”) and hydrofluroolefin (“HFO”) refrigerants and reclaimable, primarily hydrochlorofluorocarbons (“HCFC”), HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of September 30, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
CY2023Q3 us-gaap Inventory Gross
InventoryGross
144123000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
152840000
CY2023Q3 us-gaap Inventory Adjustments
InventoryAdjustments
4892000
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
7463000
CY2023Q3 us-gaap Inventory Net
InventoryNet
139231000
CY2022Q4 us-gaap Inventory Net
InventoryNet
145377000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
59583000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57405000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39013000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36837000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20570000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20568000
us-gaap Depreciation
Depreciation
2200000
us-gaap Depreciation
Depreciation
2500000
CY2023Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1291000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2372000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2173000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1283000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
799000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
960000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8878000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1739000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7139000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1972000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5167000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7139000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y25D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0824
us-gaap Operating Lease Payments
OperatingLeasePayments
2100000
us-gaap Operating Lease Payments
OperatingLeasePayments
1900000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Goodwill
Goodwill
47800000
CY2022Q4 us-gaap Goodwill
Goodwill
47800000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17528000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15469000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15433000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17564000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
CY2023Q3 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
4350191
CY2023Q3 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Non Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonVested
1.10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2444022
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y7M20D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.60
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
26900000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20600000
CY2023Q3 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
800000
CY2022Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
1100000
CY2022Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
1100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2100000
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5000000
CY2022Q4 hdsn Long Term Debt Current Net Of Other Debt.
LongTermDebtCurrentNetOfOtherDebt.
4250000
CY2023Q3 us-gaap Debt Current
DebtCurrent
5000000
CY2022Q4 us-gaap Debt Current
DebtCurrent
4250000
CY2022Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
27563000
CY2022Q4 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3578000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38985000
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
5000000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
43235000
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
90000000
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
hdsn-20230930_cal.xml Edgar Link unprocessable
0001410578-23-002221-index-headers.html Edgar Link pending
0001410578-23-002221-index.html Edgar Link pending
0001410578-23-002221.txt Edgar Link pending
0001410578-23-002221-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdsn-20230930.xsd Edgar Link pending
hdsn-20230930x10q.htm Edgar Link pending
hdsn-20230930xex31d1.htm Edgar Link pending
hdsn-20230930xex31d2.htm Edgar Link pending
hdsn-20230930xex32d1.htm Edgar Link pending
hdsn-20230930xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hdsn-20230930_def.xml Edgar Link unprocessable
hdsn-20230930_lab.xml Edgar Link unprocessable
hdsn-20230930_pre.xml Edgar Link unprocessable
hdsn-20230930x10q_htm.xml Edgar Link completed